Laura Lindsey

Dr. Laura Lindsey

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2016 in BMJ Supportive & Palliative Care
Verified
Journal Article
Closed access
PDF file
ATAdam Todd
Adam Todd
AHAndy Husband
Andy Husband
IAInga Andrew
Inga Andrew
SPSallie-Anne Pearson
Sallie-Anne Pearson
LLLaura Lindsey
Laura Lindsey
HHHolly Holmes
Holly Holmes
Objectives To systematically review the literature to examine the methods used to identify inappropriate prescribing of preventative medication in patients with life-limiting illness and to detail the nature of medications prescribed. Methods A systematic literature search of 4 databases was undertaken (MEDLINE, EMBASE, CINAHL, PsycINFO) from inception to April 2015 to identify peer-reviewed, observational studies assessing inappropriate prescribing of preventative medication in patients with life-limiting illness. Inclusion criteria were: participants had a life-limiting illness; prescribed/dispensed/using preventative medication; medication appropriateness assessed as a specific study aim or outcome. Results We found 19 studies meeting our eligibility criteria. The methods used to assess medication appropriateness included criteria developed for the elderly such as the Beers Criteria, and Screening Tool of Older Persons’ potentially inappropriate Prescriptions (STOPP) criteria, Delphi consensus and expert clinical opinion. Lipid-regulating drugs (12 studies), antihypertensive (11 studies) and antidiabetic medications (9 studies) were the most common classes of inappropriate medication identified. Conclusions Patients with life-limiting illnesses are prescribed preventative medications considered inappropriate in the context of diminished life expectancy. The way in which preventative medication appropriateness is assessed in patients with life-limiting illness varies considerably—with some methodologies utilising criteria previously developed for elderly populations. Given this lack of standardisation, improving the prescribing in this context requires an approach that is specifically designed and validated for populations with life-limiting illness.

1 October 2015 in Cancer Epidemiology
Verified
Journal Article
Open access
LLLaura Lindsey
Laura Lindsey
AHAndy Husband
Andy Husband
HNHamde Nazar
Hamde Nazar
ATAdam Todd
Adam Todd
Given that the burden of cancer is set to increase globally, strategies are needed to improve the early detection of cancer. As such, increasing focus is now placed on promoting the early detection of cancer through education and screening interventions. One healthcare setting that has significant potential in delivering these approaches is the community pharmacy. This study aimed to systematically review the literature to identify and assess the current evidence for the role of community pharmacies in delivering early cancer detection initiatives. A systematic literature search of four databases was undertaken (Medline, Embase, CINAHL, PsycINFO) from inception to June 2015 to identify peer-reviewed intervention studies. A total of 3711 articles were identified from the search, of which twelve were included in the review. The studies focused on a range of different cancers and showed it is feasible to recruit patients to education and screening interventions within a community pharmacy setting. However, the interventions were poorly described in the literature. There is significant potential for community pharmacy to deliver education and screening-based interventions to promote the early detection of cancer, but more evidence is needed to ascertain how interventions delivered in this setting impact on patient outcomes.

2 September 2016 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
LLLaura Lindsey
Laura Lindsey
AHAndy Husband
Andy Husband
LSLiz Steed
Liz Steed
RWRobert Walton
Robert Walton
ATAdam Todd
Adam Todd
Background In recent years community pharmacies have emerged as strategically important settings to deliver services aimed at promoting public health. In order to develop evidence-based approaches to public health interventions that exploit the unique accessibility of community pharmacies, it is important to determine how people experience care in this context. This study, therefore, aimed to describe how care is perceived and experienced in community pharmacies with particular focus on community pharmacy access. Methods In-depth semi-structured interviews were used to explore the perceptions and experiences’ of people using community pharmacies. Results A total of 30 participants were interviewed. Themes specifically emerged in relation to community pharmacy access; these fell into four main categories: relationships; time; lack of awareness; and empowerment. Conclusions The experience of developing a trusting relationship with the pharmacist is an important consideration in the context of community pharmacy accessibility. This could be an important consideration when a person uses a community pharmacy to access a public health service. There is also a perceived lack of awareness among the general public about the extended role of community pharmacy; this is a potential barrier toward people using them.

10 November 2005 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RJRay Jones
Ray Jones
RRRay Rogers
Ray Rogers
JRJean Roberts
Jean Roberts
LCLynne Callaghan
Lynne Callaghan
LLLaura Lindsey
Laura Lindsey
GWGraham R Williamson
Graham R Williamson
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

25 February 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
MAMaha Alkhaldi
Maha Alkhaldi
LLLaura Lindsey
Laura Lindsey
CRCharlotte Richardson
Charlotte Richardson
Objectives To explore the literature about the role of unpaid informal carers in medication management for people with long-term conditions. Design Systematic review designed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Information source MEDLINE (Ovid), Embase (Ovid), PsycINFO, Cumulated Index in Nursing and Allied Health Literature (EBSCO), Scopus and Web of Science were searched from inception until April 2024. Additional papers were identified by searching backwards and forwards the reference lists of included papers. Eligibility criteria Primary research studies were included if they reported medication-related activities undertaken by carers for people with long-term conditions. Qualitative and mixed methods studies were considered without restriction on language or country. Data extraction and synthesis Relevant data were extracted and summarised in a table. The Mixed Method Appraisal Tool was used for quality assessment. Data were narratively synthesised. Results From 12 473 identified records, 107 underwent full text screening and 20 studies were included. Family carers were the predominant type of carer. Spouses and adult children constituted the largest caregiving dyads. Based on the required skills, two groups of roles were identified: physical roles, such as prescription management, and cognitive roles, such as decision-making. Carers used different strategies and tools to undertake medication-related activities including compliance aids and alarms. However, carers reported challenges in their experiences of caregiving, flagging up their need for additional support and education to commence such activities. Conclusion Informal carers undertake a wide variety of medication-related activities. The studies emphasised the need to support families as partners in health outcomes. This systematic review identifies the importance of bridging the gap between carers and healthcare providers. More efforts are needed to empower carers towards better and safer caregiving. Future work could address how to optimise carer involvement and engagement and provide best practice recommendations for carers’ support. PROSPERO registration number CRD42024506694.

19 February 2015 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
JBJay Badenhorst
Jay Badenhorst
ATAdam Todd
Adam Todd
LLLaura Lindsey
Laura Lindsey
JLJonathan Ling
Jonathan Ling
AHAndy Husband
Andy Husband